Last reviewed · How we verify
NCT05062902
A Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management
EARLY_PHASE1 trial testing High Density Surface Electromyographic, precision botulinum neurotoxin injection guidance medical device in Interstitial Cystitis in 46 participants. Not yet recruiting.
15 August 2027
Quick facts
| Lead sponsor | HillMed Inc. |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 46 |
| Start date | 15 September 2025 |
| Primary completion | 15 August 2027 |
| Estimated completion | 1 December 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- High Density Surface Electromyographic, precision botulinum neurotoxin injection guidance medical device
- Botulinum Neurotoxin — full drug profile →
Conditions studied
- Interstitial Cystitis — all drugs for Interstitial Cystitis →
- Chronic Pain — all drugs for Chronic Pain →
- Pelvic Floor; Relaxation — all drugs for Pelvic Floor; Relaxation →
- Pelvic Floor Disorders — all drugs for Pelvic Floor Disorders →
Sponsor
HillMed Inc.
Who can join
Adults 18 to 60, female only, with Interstitial Cystitis or Chronic Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate if it is possible to use intravaginal high-density surface electromyography to guide Botulinum neurotoxin (BoNT) injection to treat pelvic floor muscle overactivity that complicates Chronic Pelvic Pain (CPP).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05062902
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High Density Surface Electromyographic, precision botulinum neurotoxin injection guidance medical device
Trials testing the same drug.
- NCT06796985 — Botox for Chronic Pelvic Pain · Phase 1 · recruiting
Other recruiting trials for Interstitial Cystitis
Currently open trials in the same condition.
- NCT06299683 — Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment · NA · recruiting
- NCT05696444 — Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO) · NA · active not recruiting
- NCT05485207 — Transvaginal Botulinum Toxin A for Interstitial Cystitis / Bladder Pain Syndrome · EARLY_PHASE1 · active not recruiting
- NCT04734847 — Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome · NA · recruiting
- NCT00499317 — Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05062902 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by HillMed Inc.
- Last refreshed: 19 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05062902.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing